Himalaya (Diabecon)

Type–2 diabetes is characterized by insulin resistance and therefore high level of glucose in blood. This leads to severe damage to organs, primarily the cardiac system. Over 20 million people are diagnosed with type–2 in the USA alone. The main cause is the cell’s inability to assimilate glucose. Himalaya Diabecon affects the process by stimulating the b–cell regeneration. It doesn’t cure the type–2 diabetes but significantly helps to relieve the consequences.